244 related articles for article (PubMed ID: 12044272)
1. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
[TBL] [Abstract][Full Text] [Related]
3. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults.
Loebermann M; Kollaritsch H; Ziegler T; Rendi-Wagner P; Chambonneau L; Dumas R; Lafrenz M
Clin Ther; 2004 Jul; 26(7):1084-91. PubMed ID: 15336473
[TBL] [Abstract][Full Text] [Related]
4. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity.
Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F
J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576
[TBL] [Abstract][Full Text] [Related]
5. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
Overbosch D; Peyron F; Picot N; Varichon JP; Dumas R; Chambonneau L; Weber F
J Travel Med; 2005; 12(6):319-26. PubMed ID: 16343383
[TBL] [Abstract][Full Text] [Related]
6. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study.
Lau CL; Streeton CL; David MC; Sly PD; Mills DJ
J Travel Med; 2016 Feb; 23(2):tav023. PubMed ID: 26883924
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for travelers.
Med Lett Drugs Ther; 2018 Nov; 60(1560):185-192. PubMed ID: 30625125
[No Abstract] [Full Text] [Related]
9. A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults.
Beran J; Chlibek R; Weber F
Vaccine; 2003 Dec; 21(32):4650-4. PubMed ID: 14585671
[TBL] [Abstract][Full Text] [Related]
10. Expanded table: Some vaccines for travelers.
Med Lett Drugs Ther; 2018 Nov; 60(1560):e192-e194. PubMed ID: 30625127
[No Abstract] [Full Text] [Related]
11. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
Proell S
BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
[No Abstract] [Full Text] [Related]
12. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
[TBL] [Abstract][Full Text] [Related]
13. Vaccinations for international travellers travelling from Greece.
Pavli A; Spilioti A; Lymperi I; Katerelos P; Maltezou HC
Travel Med Infect Dis; 2013; 11(4):225-30. PubMed ID: 23433917
[TBL] [Abstract][Full Text] [Related]
14. Vaccinations and malaria prophylaxis for long-term travellers travelling from Greece: a prospective, questionnaire-based analysis.
Pavli A; Smeti P; Spilioti A; Silvestros C; Katerelos P; Maltezou HC
Travel Med Infect Dis; 2014; 12(6 Pt B):764-70. PubMed ID: 24957561
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
[TBL] [Abstract][Full Text] [Related]
16. Concomitant vaccination against hepatitis A and typhoid fever.
Van Hoecke C; Lebacq E; Beran J; Prymula R; Collard F
J Travel Med; 1998 Sep; 5(3):116-20. PubMed ID: 9772328
[TBL] [Abstract][Full Text] [Related]
17. New and improved vaccines. Promising weapons against varicella, hepatitis A, and typhoid fever.
Conrad DA; Jenson HB
Postgrad Med; 1996 Oct; 100(4):113-8, 121-5, 127. PubMed ID: 8858086
[TBL] [Abstract][Full Text] [Related]
18. Concomitant use of VAQTA with PedvaxHIB and Infanrix in 12 to 17 month old children.
Petrecz M; Ramsey KP; Stek JE; Martin JC; Klopfer SO; Kuter B; Schödel FP; Lee AW
Hum Vaccin Immunother; 2016; 12(2):503-11. PubMed ID: 26308112
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial.
Sirima SB; Ouedraogo A; Barry N; Siribie M; Tiono A; Nébié I; Konaté A; Berges GD; Diarra A; Ouedraogo M; Bougouma EC; Soulama I; Hema A; Datta S; Liang Y; Rotrosen ET; Tracy JK; Jamka LP; Oshinsky JJ; Pasetti MF; Neuzil KM; Laurens MB
Int J Infect Dis; 2021 Jul; 108():465-472. PubMed ID: 34082090
[TBL] [Abstract][Full Text] [Related]
20. Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
Guerra FA; Gress J; Werzberger A; Reisinger K; Walter E; Lakkis H; Grosso AD; Welebob C; Kuter BJ;
Pediatr Infect Dis J; 2006 Oct; 25(10):912-9. PubMed ID: 17006287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
